Professor Christl Donnelly
Contact information
Colleges
Christl Donnelly
CBE FMedSci FRS
Professor of Applied Statistics
My research programme brings together and develops statistical and biomathematical methods to analyse epidemiological patterns of infectious diseases. I have studied a variety of diseases, with a particular interest in outbreaks. I also have interests in ecology, conservation and animal welfare.
I use rigorous parameter estimation and hypothesis testing to gain the robust insights from dynamical models of disease transmission, demography and interventions. My research programme aims to improve our understanding of (and ability to predict) the effect of interventions on infectious agent transmission dynamics and population structure. The ultimate goal is to make control strategies as effective as they can be.
I have studied many infectious diseases, including Zika virus, Ebola, MERS, influenza, SARS, bovine TB, foot-and-mouth disease, rabies, cholera, dengue, BSE/vCJD, malaria and HIV/AIDS. I was a leading member of the WHO Ebola Response Team (2014-2016). I was also deputy chair of the Independent Scientific Group on Cattle TB (1998-2007) which designed, oversaw and analysed the Randomised Badger Culling Trial.
I studied mathematics as an undergraduate at Oberlin College and biostatistics as a graduate student at Harvard School of Public Health.
Recent publications
-
Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in England.
Journal article
Eales O. et al, (2023), PLoS biology, 21
-
Sir David Cox—A Life Well Lived
Journal article
Donnelly CA., (2023), Issue 5.2, Spring 2023, 5
-
LONG-TERM PHYSICAL AND MENTAL HEALTH IMPACT OF COVID-19 ON ADULTS IN ENGLAND: FOLLOW UP OF A LARGE RANDOM COMMUNITY SAMPLE
Preprint
Atchison CJ. et al, (2023)
-
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19.
Journal article
Kartsonaki C. et al, (2023), International journal of epidemiology, 52, 355 - 376
-
The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021.
Journal article
Eales O. et al, (2023), Microbial genomics, 9